Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary Neoplasms 1

Interventions

Proton Therapy 2Trimethoprim 1Surgical Procedures, Operative 1Sulfamethoxazole 1Radiation Dose Hypofractionation 1Protons 1Neuropsychological Tests 1Hormone Replacement Therapy 1Deamino Arginine Vasopressin 1Critical Pathways 1Clinical Laboratory Techniques 1Cefdinir 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pituitary Neoplasms × Hormone Replacement Therapy × Clear all
NCT06679816 2025-01-14

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Beijing Tiantan Hospital

Phase 4 Recruiting
882 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡